JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 10 1707-1713
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilland, D. R.
Right arrow Articles by Coleman, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilland, D. R.
Right arrow Articles by Coleman, R. E.

Volume and Activity Quantitation with Iodine-123 SPECT

David R. Gilland, Ronald J. Jaszczak, Timothy G. Turkington, Kim L. Greer and R. Edward Coleman

Department of Radiology, Duke University Medical Center, Durham, North Carolina

Correspondence: For correspondence and reprints contact: David R. Gilland, PhD, Dept., of Radiology, Box 3949, Duke University Medical Center, Durham NC 27710.

ABSTRACT

The goals of this study were to investigate the effect of septal penetration on 123I SPECT activity quantitation using low-energy, high-resolution collimators, and to evaluate a semi-automatic method for measuring volume and activity of 123I distribution with SPECT. Methods: Data were acquired from experimental phantoms containing spheres filled with a high-purity 123I solution. The penetration study compared the reconstructed activity of a 3.4-cm diameter sphere with and without the presence of surrounding activity. In the study of volume and activity quantitation, three different size spheres (diameters of 1.8 cm, 2.8 cm and 3.4 cm) were imaged in three different sphere-to-background (S:B) 123I concentration ratios (2.5, 5 and 10) with low-energy collimators. The filtered backprojection reconstruction method was used with compensation for scatter, attenuation and detector response. Volume and activity measurements were obtained from the SPECT image using a semiautomatic gradient technique which estimates the location of the sphere/boundary in three dimensions. Results: With the low-energy collimator, there was only a small (<2%)increase in the measured activity of the sphere when surrounding activity was present. The measured volume for the two largest spheres was within 5% of the true volume for all S:B ratios. The activity measurement of these spheres was consistently underestimated by 20%–25% but suggested that the accuracy could be improved with calibration. For the smallest sphere, the volume was grossly overestimated and only at the 10 S:B ratio was the activity measured reasonably accurately (<20%). Conclusions: The low-energy collimators used in this study are suitable for quantitative 123I SPECT. Accurate SPECT volume and activity quantitation of 123 distribution can be achieved by semiautomatic means at clinical count densities for objects as small as 2.8 cm in diameter and reasonable activity quantitation is possible for smaller objects with an S:B ratio of at least 10.

Key Words: iodine-123 • SPECT • activity quantitation • volume quantitation • septal penetration




This article has been cited by other articles:


Home page
JNMHome page
M. G. Stabin
Uncertainties in Internal Dose Calculations for Radiopharmaceuticals
J. Nucl. Med., May 1, 2008; 49(5): 853 - 860.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. El Fakhri, S. C. Moore, P. Maksud, A. Aurengo, and M. F. Kijewski
Absolute Activity Quantitation in Simultaneous 123I/99mTc Brain SPECT
J. Nucl. Med., February 1, 2001; 42(2): 300 - 308.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.